A system for real-time monitoring of radiation therapy delivery
DoseRT™ : A Non-Contact Optical Patient and Beam Dosimetry System for Continuous in vivo Radiotherapy Verification
This study is testing a new, easy-to-use system called DoseRT™ that helps make sure radiation therapy for cancer is delivered accurately and safely, so patients can feel more confident about their treatment and have a lower risk of side effects.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Doseoptics, LLC NIH-funded |
| Lab location | 1 site (Lebanon, United States) |
| Project ID | NIH-11115803 on NIH RePORTER |
What this research studies
This research focuses on developing a non-contact optical system called DoseRT™ that continuously verifies the delivery of radiation therapy during treatment. By utilizing Cherenkov imaging technology, the system captures real-time data on how radiation is administered to ensure precision and minimize the risk of side effects. This innovative approach aims to enhance the safety and effectiveness of radiation therapy, which is a common treatment for various cancers. Patients undergoing radiation therapy may benefit from improved treatment accuracy and reduced chances of secondary cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients receiving radiation therapy for cancer treatment.
Not a fit: Patients who are not undergoing radiation therapy or those receiving alternative cancer treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the safety and effectiveness of radiation therapy for cancer patients.
How similar studies have performed: Similar approaches using imaging technologies in radiation therapy have shown promise, indicating potential for success in this novel application.
Where this research is happening
Lebanon, United States
- Doseoptics, LLC — Lebanon, United States (Active)
Researchers
- Principal investigator: Ware, William — Doseoptics, LLC
- Study coordinator: Ware, William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.